NYX ‐2925, A Novel N‐methyl‐D‐aspartate Receptor Modulator: A First‐in‐Human, Randomized, Double‐blind Study of Safety and Pharmacokinetics in Adults

Clinical and Translational Science, EarlyView.

Source: Clinical and Translational Science - September 29, 2018 Category: Biomedical Science Authors: David R. Houck, Laurel Sindelar, Carlos R. Sanabria, Stephanie H. Stanworth, Maggie Krueger, Mary Suh, Torsten M. Madsen Source Type: research